Evidence map›Paper›PMID 30409089›Full record

ArticleInnate immunity2018

Synergistic effect of phosphodiesterase 4 inhibitor and serum on migration of endotoxin-stimulated macrophages.

Jing-Xing Yang, Te-Chih Hsiung, Fu-Chun Weng, Shiau-Li Ding, Chin-Pyng Wu, Marco Conti, Tsung-Hsien Chuang, S-L Catherine Jin

Open access · hybridAbstract read
In one paragraph

Article in Innate immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Genetic Risk Factors of Intracranial Atherosclerosis.Current atherosclerosis reports · 2020
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jing-Xing Yang1 National Central University, Taoyuan City, Taiwan.
Te-Chih Hsiung2 Landseed Hospital, Taoyuan City, Taiwan.
Fu-Chun Weng1 National Central University, Taoyuan City, Taiwan.
Shiau-Li Ding1 National Central University, Taoyuan City, Taiwan.
Chin-Pyng Wu2 Landseed Hospital, Taoyuan City, Taiwan.
Marco Conti3 Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, USA.
Tsung-Hsien Chuang4 Immunology Research Center, National Health Research Institutes, Miaoli.
S-L Catherine Jin1 National Central University, Taoyuan City, Taiwan.
National Central University · TWLandseed Hospital · TWNational Health Research Institutes · TWUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophage migration is an essential step in host defense against infection and wound healing. Elevation of cAMP by inhibiting phosphodiesterase 4 (PDE4), enzymes that specifically degrade cAMP, is known to suppress various inflammatory responses in activated macrophages, but the role of PDE4 in macrophage migration is poorly understood. Here we show that the migration of Raw 264.7 macrophages stimulated with LPS was markedly and dose-dependently induced by the PDE4 inhibitor rolipram as assessed by scratch wound healing assay. Additionally, this response required the involvement of serum in the culture medium as serum starvation abrogated the effect. Further analysis revealed that rolipram and serum exhibited synergistic effect on the migration, and the influence of serum was independent of PDE4 mRNA expression in LPS-stimulated macrophages. Moreover, the enhanced migration by rolipram was mediated by activating cAMP/exchange proteins directly activated by cAMP (Epac) signaling, presumably via interaction with LPS/TLR4 signaling with the participation of unknown serum components. These results suggest that PDE4 inhibitors, together with serum components, may serve as positive regulators of macrophage recruitment for more efficient pathogen clearance and wound repair.

Indexed as

AnimalsCell MovementCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 4InflammationLipopolysaccharidesMacrophagesMicePhosphodiesterase 4 InhibitorsRAW 264.7 CellsRolipramSerumSignal TransductionWound HealingCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 4LipopolysaccharidesPhosphodiesterase 4 InhibitorsRolipramcAMP/Epac signalinginflammationmacrophage migrationPhosphodiesterase 4serum

Identifiers

PMID30409089
PMCPMC6830870
OpenAlexW2899574714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.